Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient-Reference-Cited by-同舟云学术

Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient

Published:2024-02 Issue: Volume:Volume 17 Page:531-541
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Tanino Yoko,Nishioka Keisuke,Yamamoto Chie,Watanabe Yohei^ORCID,Daidoji Tomo,Kawamoto Masataka,Uda Sayaka,Kirito Shoko,Nakagawa Yuta,Kasamatsu Yu,Kawahara Yoshiyuki^ORCID,Sakai Yuri^ORCID,Nobori Shuji,Inaba Tohru^ORCID,Ota Bon,Fujita Naohisa,Hoshino Atsushi,Nukui Yoko,Nakaya Takaaki^ORCID

Publisher

Informa UK Limited

Reference22 articles.

1. Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant

2. Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use

3. Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab

4. Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients

5. Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical validation of an RSV neutralization assay and testing of cross-sectional sera pre- and post- RSV outbreaks from 2021-2023;2024-06-14

2. RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial;Advances in Respiratory Medicine;2024-05-06

3. Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019;Viruses;2024-04-30

4. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04

5. Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient [Corrigendum];Infection and Drug Resistance;2024-03